Unknown

Dataset Information

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial.


ABSTRACT:

Objectives

To study the effects of metformin on the incidence of vitamin B-12 deficiency (<150 pmol/l), low concentrations of vitamin B-12 (150-220 pmol/l), and folate and homocysteine concentrations in patients with type 2 diabetes receiving treatment with insulin.

Design

Multicentre randomised placebo controlled trial.

Setting

Outpatient clinics of three non-academic hospitals in the Netherlands.

Participants

390 patients with type 2 diabetes receiving treatment with insulin.

Intervention

850 mg metformin or placebo three times a day for 4.3 years.

Main outcome measures

Percentage change in vitamin B-12, folate, and homocysteine concentrations from baseline at 4, 17, 30, 43, and 52 months.

Results

Compared with placebo, metformin treatmen

SUBMITTER: de Jager J 

PROVIDER: S-EPMC2874129 | biostudies-literature | 2010 May

REPOSITORIES: biostudies-literature